Phase I/II-study of temozolomide combined with radiation as postoperative treatment in primary glioblastoma multiforme

被引：0
|
作者：
Combs, SE
Gutwein, S
Schulz-Ertner, D
Van Kampen, M
Wannenmacher, M
Thilmann, C
Debus, J
机构：
[1] Univ Heidelberg, Dept Radiat Oncol, Heidelberg, Germany
[2] Nordwestkrankenhaus, Frankfurt, Germany
[3] German Canc Res Ctr DKFZ, Heidelberg, Germany
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2004年 / 60卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1003
引用
收藏
页码：S258 / S259
页数：2
相关论文
共 50 条
  • [1] Temozolomide combined with irradiation as postoperative treatment of primary glioblastoma multiforme - Phase I/II study
    Combs, SE
    Gutwein, S
    Schulz-Ertner, D
    van Kampen, M
    Thilmann, C
    Edler, L
    Wannenmacher, MM
    Debus, J
    STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 (06) : 372 - 377
  • [2] Temozolomide combined with radiation as first-line treatment in primary gliablastoma multiforme: Phase I/II-study.
    Combs, SE
    Gutwein, S
    Schulz-Ertner, D
    Van Kampen, M
    Thilmann, C
    Wannenmacher, MM
    Debus, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 114S - 114S
  • [3] Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients
    Combs, Stephanie E.
    Wagner, Johanna
    Bischof, Marc
    Welzel, Thomas
    Wagner, Florian
    Debus, Juergen
    Schulz-Ertner, Daniela
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 70 (04): : 987 - 992
  • [4] Treatment of primary glioblastoma multiforme with cetuximab, radiotherapy and temozolomide (GERT) - phase I/II trial: study protocol
    Combs, Stephanie E.
    Heeger, Steffen
    Haselmann, Renate
    Edler, Lutz
    Debus, Juergen
    Schulz-Ertner, Daniela
    BMC CANCER, 2006, 6 (1)
  • [5] Treatment of primary glioblastoma multiforme with cetuximab, radiotherapy and temozolomide (GERT) – phase I/II trial: study protocol
    Stephanie E Combs
    Steffen Heeger
    Renate Haselmann
    Lutz Edler
    Jürgen Debus
    Daniela Schulz-Ertner
    BMC Cancer, 6
  • [6] Enzastaurin plus temozolomide with radiation therapy in glioblastoma multiforme: A phase I study
    Butowski, Nicholas
    Chang, Susan M.
    Lamborn, Kathleen R.
    Polley, Mei Yin
    Parvataneni, R.
    Hristova-Kazmierski, Maria
    Musib, Luna
    Nicol, Steven J.
    Thornton, Donald E.
    Prados, Michael D.
    NEURO-ONCOLOGY, 2010, 12 (06) : 608 - 613
  • [7] Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme
    Chang, SM
    Lamborn, KR
    Malec, M
    Larson, D
    Wara, W
    Sneed, P
    Rabbitt, J
    Page, M
    Nicholas, MK
    Prados, MD
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (02): : 353 - 357
  • [8] Temozolomide combined with interferon-γ in the postoperative treatment of primary glioblastoma
    Yang, XF
    Zheng, XS
    Liu, WG
    ONCOLOGY RESEARCH, 2006, 15 (10-12) : 500 - 500
  • [9] Temozolomide Combined with Irradiation as Postoperative Treatment of Primary Glioblastoma MultiformePhase I/II StudyRadiochemotherapie mit Temozolomid zur postoperativen Behandlung von Patienten mit primärem Glioblastoma multiforme. Phase-I/II-Studie
    Stephanie E. Combs
    Sybille Gutwein
    Daniela Schulz-Ertner
    Michael van Kampen
    Christoph Thilmann
    Lutz Edler
    Michael M. Wannenmacher
    Jürgen Debus
    Strahlentherapie und Onkologie, 2005, 181 (6) : 372 - 377
  • [10] Combined Thalidomide and Temozolomide Treatment in Patients with Glioblastoma Multiforme
    Fabian Baumann
    Miroslava Bjeljac
    Spyros S. Kollias
    Brigitta G. Baumert
    Sebastian Brandner
    Valentin Rousson
    Yasuhiro Yonekawa
    René L. Bernays
    Journal of Neuro-Oncology, 2004, 67 : 191 - 200
12345